Fiduciary Trust International of Pennsylvania’s GSK GSK Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$905K	Buy	19,114 +608	+3%	+$32.4K	0.04%	223
2019 Q4	$1.09M	Hold	18,506	–	–	0.04%	208
2019 Q3	$987K	Sell	18,506 -1,337	-7%	-$68.8K	0.04%	233
2019 Q2	$993K	Buy	19,843 +83	+0.4%	+$4.17K	0.04%	240
2019 Q1	$1.03M	Hold	19,760	–	–	0.04%	209
2018 Q4	$944K	Buy	19,760 +1,000	+5%	+$49.2K	0.05%	202
2018 Q3	$942K	Sell	18,760 -3,200	-15%	-$163K	0.04%	237
2018 Q2	$1.11M	Buy	21,960 +800	+4%	+$40.3K	0.05%	216
2018 Q1	$1.03M	Sell	21,160 -240	-1%	-$11.2K	0.05%	240
2017 Q4	$948K	Sell	21,400 -377	-2%	-$17.4K	0.04%	249
2017 Q3	$1.1M	Sell	21,777 -2,391	-10%	-$121K	0.05%	206
2017 Q2	$1.3M	Buy	24,168 +6,882	+40%	+$367K	0.06%	213
2017 Q1	$911K	Sell	17,286 -744	-4%	-$37.7K	0.07%	168
2016 Q4	$868K	Sell	18,030 -1,905	-10%	-$94.1K	0.07%	168
2016 Q3	$1.07M	Buy	19,935 +699	+4%	+$38.3K	0.09%	162
2016 Q2	$1.04M	Sell	19,236 -261	-1%	-$13.8K	0.08%	161
2016 Q1	$988K	Sell	19,497 -99	-0.5%	-$4.93K	0.08%	157
2015 Q4	$988K	Sell	19,596 -1,096	-5%	-$55.9K	0.08%	155
2015 Q3	$995K	Sell	20,692 -8,782	-30%	-$457K	0.09%	148
2015 Q2	$1.53M	Buy	29,474 +4,788	+19%	+$270K	0.09%	179
2015 Q1	$1.42M	Buy	24,686 +1,004	+4%	+$57.6K	0.09%	159
2014 Q4	$1.26M	Sell	23,682 -1,404	-6%	-$78.5K	0.08%	169
2014 Q3	$1.44M	Sell	25,086 -2,891	-10%	-$177K	0.1%	164
2014 Q2	$1.87M	Sell	27,977 -999	-3%	-$67.6K	0.13%	144
2014 Q1	$1.94M	Buy	28,976 +488	+2%	+$33K	0.14%	145
2013 Q4	$1.9M	Sell	28,488 -1,332	-4%	-$86.4K	0.14%	147
2013 Q3	$1.87M	Buy	29,820 +896	+3%	+$57.7K	0.15%	150
2013 Q2	$1.81M	Buy	+28,924	New	+$1.84M	0.16%	145

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's GSK Position: Q1 2020 in Review

Fiduciary Trust International of Pennsylvania increased its GSK (GSK) stake by 3.3% in Q1 2020, buying an estimated $32.4K and bringing the position to 19,114 shares worth $905K. The position accounts for 0.04% of the portfolio, ranked #223.

Fiduciary Trust International of Pennsylvania first reported a position in GSK in Q2 2013 and has held it in 28 quarters since. The position peaked at $1.94M in Q1 2014. 818 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

Fiduciary Trust International of Pennsylvania held 19,114 shares of GSK worth $905K as of Q1 2020.
Fiduciary Trust International of Pennsylvania bought 608 GSK shares in Q1 2020, an estimated $32.4K.
GSK made up 0.04% of Fiduciary Trust International of Pennsylvania's portfolio in Q1 2020, its #223 holding.
Fiduciary Trust International of Pennsylvania first reported a position in GSK in Q2 2013 and has held it in 28 quarters since.
Fiduciary Trust International of Pennsylvania's GSK position peaked at $1.94M in Q1 2014.
818 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q1 2020, filed 27 Apr 2020.